In particular, a subset of women (41.7%) had a decrease in TRAIL from time 1 to time 3 >20 pg/ml, showing a decrease in the levels of circulating TRAIL similar to that previously observed in patients affected by coronary artery disease [5]–[9]. The gene discussed is TNFSF10; the disease is coronary artery disorder.